Company · Healthtech & Bio

InnoUp Farma

innoupfarma.com ↗ ·Pamplona ·Series A

InnoUp Farma is a clinical-stage Spanish biopharmaceutical company developing a patented nanoparticle-based platform to enable oral (rather than injectable) delivery of drugs with low bioavailability. Its lead programs include an oral peanut allergy immunotherapy and an oral paclitaxel treatment for breast cancer. Founded in 2013 in Navarre, Spain, it is backed by Inveready and Spanish public funding bodies (SODENA, CDTI).

Founded

2013

Founders

News

Rounds

Investors

SectorsNanomedicine, Biopharmaceuticals, Drug Delivery Start-up MapHealthtech & Bio › Drug discovery & therapeutics developers

Profile updated 1 Aug 2026

Founders

Juan M. Irache

Co-Founder

Maite Agüeros

Co-Founder & CEO

Global models 5

Selecta Biosciences

United States · www.selectabio.com ↗

Clinical-stage biotech using a nanoparticle immune-modulation platform (ImmTOR), directly comparable to InnoUp's nanoparticle-based approach to immune tolerance/allergy programs.

$398MComparable

Lyndra Therapeutics

United States · www.lyndra.com ↗

Develops an oral drug delivery platform for ultra-long-acting sustained release, the same core value proposition as InnoUp's oral bioadhesive nanoparticle platform.

$305MComparable

Chiasma

United States · www.chiasma.com ↗

Developed a proprietary oral delivery technology (TPE) to convert an injectable biologic (octreotide) into a pill, mirroring InnoUp's oral paclitaxel conversion strategy.

$260MComparable

Rani Therapeutics

United States · www.ranitherapeutics.com ↗

Clinical-stage company replacing injectable biologics with oral delivery technology, the same oral-bioavailability thesis as InnoUp's nanoparticle platform.

$226MComparable

Applied Molecular Transport

United States · www.appliedmt.com ↗

Biotech building a proprietary oral delivery platform for biologics and drugs with poor bioavailability, closely matching InnoUp's core technology focus.

$142MComparable